I agree...Metabolic's value is only derived from ACV1. Forgetting the preclinical pipeline, the only product Metabolic has is ACV1. If ACV1 fails, Metabolic is Game Over, effectively. If ACV2 suceeds in this Phase 2A trial, then the company goes on.
I agree...Metabolic's value is only derived from ACV1....
Add to My Watchlist
What is My Watchlist?